文献速递临床微生物质量管理与危急值

伊丽莎白菌属抗菌药物敏感性:参考实验室报告

Antimicrobial Susceptibility of Elizabethkingia Species: Report from a Reference Laboratory.
PubMed 文献 · J Clin Microbiol · 2022-05-05

结果显示所有受试菌株对米诺环素敏感(18/18;100%),90%的菌株对甲氧苄啶-磺胺甲噁唑敏感(117/130)。不同菌种对哌拉西林-他唑巴坦和左氧氟沙星的敏感性存在差异。

要点

  • 米诺环素对伊丽莎白菌属体外敏感性高(18/18;100%)。
  • 90%的伊丽莎白菌属分离株对甲氧苄啶-磺胺甲噁唑敏感(117/130)。
  • 不同菌种间抗菌药物敏感性存在差异,需进一步研究临床意义。

核心结论

  • 伊丽莎白菌属对米诺环素和甲氧苄啶-磺胺甲噁唑呈现高体外敏感率。
  • 菌种间抗菌药物敏感性差异的临床意义有待进一步研究。

研究设计与样本

  • 菌种鉴定方法包括生化面板、MALDI-TOF MS和16S rRNA基因测序。
  • 采用琼脂稀释法进行抗菌药物敏感性试验。

主要发现

  • 儿科患者标本以下呼吸道为主(20/37;54%),成人以血液为主(62/137;45%)。
  • 鉴定菌种中脑膜炎败血伊丽莎白菌占多数(72/121;59%)。
  • 所有受试菌株对米诺环素敏感(18/18;100%)。
  • 90%的受试菌株对甲氧苄啶-磺胺甲噁唑敏感(117/130)。
  • 12株伊丽莎白菌 miricola 中,多数对哌拉西林-他唑巴坦(11/12;92%)和左氧氟沙星(11/12;92%)敏感;14株伊丽莎白菌 anophelis 中,多数对哌拉西林-他唑巴坦(13/14;93%)敏感。

关键数值与推荐

  • 米诺环素敏感率:18/18(100%)。
  • 甲氧苄啶-磺胺甲噁唑敏感率:117/130(90%)。
  • 伊丽莎白菌 miricola 对哌拉西林-他唑巴坦敏感率:11/12(92%);对左氧氟沙星敏感率:11/12(92%)。
  • 伊丽莎白菌 anophelis 对哌拉西林-他唑巴坦敏感率:13/14(93%)。

临床怎么用

  • 米诺环素和甲氧苄啶-磺胺甲噁唑可作为伊丽莎白菌属感染的潜在治疗选择。
  • 临床用药需考虑菌种间敏感性差异,并参考药敏试验结果。

局限性

  • 菌种鉴定方法随时间变化,可能影响菌种归类的一致性。
  • 部分菌种药敏试验的菌株数较少。
  • 菌种间敏感性差异的临床意义尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Elizabethkingia species are Gram-negative bacilli that were most recently linked to a cluster of infections in the Midwestern United States from 2016 to 2017. Inappropriate empirical and directed antibiotic selection for this organism is common among providers and is an independent risk factor for mortality. Trends in antimicrobial susceptibility profiles of Elizabethkingia species from a referral laboratory over a 10-year period were reviewed. Identification methods used over time varied and included biochemical panels, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and 16S rRNA gene sequencing. Agar dilution was used to conduct antimicrobial susceptibility testing. One hundred seventy-four clinical isolates were included. The lower respiratory tract (20/37; 54%) was the most common specimen source in pediatric patients, whereas blood isolates (62/137; 45%) constituted the most prevalent source in adults. Among the identified species, Elizabethkingia meningoseptica (72/121; 59%) constituted the majority. All Elizabethkingia species tested against minocycline were susceptible (18/18; 100%), and 90% of isolates tested against trimethoprim-sulfamethoxazole (TMP-SMX) (117/130) were susceptible. Of the 12 Elizabethkingia miricola isolates, most of the tested isolates were susceptible to piperacillin-tazobactam (11/12; 92%) and levofloxacin (11/12; 92%), whereas the Elizabethkingia anophelis isolates most often tested susceptible to piperacillin-tazobactam (13/14; 93%). In this study, Elizabethkingia species showed high rates of in vitro susceptibility to minocycline and TMP-SMX. Further studies are needed to investigate the clinical implications of species-level differences in antimicrobial susceptibilities in this genus.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Comba IY, Schuetz AN, Misra A, et al. Antimicrobial Susceptibility of Elizabethkingia Species: Report from a Reference Laboratory. J Clin Microbiol. 2022. PMID: 35510517. doi:10.1128/jcm.02541-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。